SCHEMBL6821772

SCHEMBL6821772

NC(=O)C(N)(c1ccccc1)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.50
CES2 O00748 1/20 0.50
CYP19A1 P11511 1/20 0.50
TSHR P16473 1/20 0.49
ALDH1A1 P00352 4/20 0.48
LMNA P02545 3/20 0.48
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MITF O75030 1/20 0.47
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GAA P10253 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
CRHBP P24387 1/20 0.43
ATM Q13315 1/20 0.43
CRHR2 Q13324 1/20 0.43
TLR9 Q9NR96 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27449202 0.86 TSHR (0.51) CES1CES2TSHRALDH1A1LMNA
SCHEMBL6871299 0.83 CYP19A1 (0.54) CES1CES2CYP19A1TSHRALDH1A1
SCHEMBL4800395 0.82 CYP19A1 (0.49) CES1CES2CYP19A1TSHRALDH1A1
SCHEMBL8169066 0.82 MAPT (0.58) TSHRLMNAPOLBKMT2ATDP1
SCHEMBL27932154 0.77 TSHR (0.57) CES1TSHRALDH1A1LMNAPOLB
SCHEMBL9145056 0.76 CYP19A1 (0.56) CES1CES2CYP19A1ALDH1A1LMNA
SCHEMBL4592812 0.76 CYP19A1 (0.56) CES1CES2CYP19A1ALDH1A1LMNA
SCHEMBL9144366 0.76 CYP19A1 (0.56) CES1CES2CYP19A1ALDH1A1LMNA
SCHEMBL10886554 0.76 TSHR (0.52) CES1TSHRALDH1A1LMNAPOLB
Nitrobenzene SCHEMBL1006772 0.76 LMNA (0.76) CES1CES2TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022534-A1 ARYLGLYCINE DERIVATIVES FOR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed